Status: Recruiting
A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
The goal of this observational prospective study is to evaluate wound healing outcomes in resection wounds resulting from surgical removal of cutaneous malignancies treated with a synthetic electrospun fiber matrix. This study intends to quantify the time from initial resection and product application to time of complete granulation of the wound bed in weeks.
Participants needed: 34
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Acera Surgical, Inc.Updated: Jun 18, 2026Locations: 1
Eligibility criteria
Patient is at least 18 years old [+4]
Inability to give informed consent or to complete the procedures required for st... [+20]